Vertex Pharmaceuticals Incorporated (LON:0QZU)
London · Delayed Price · Currency is GBP · Price in USD 393.58
+10.85 (2.84%)
At close: Aug 13, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 73.90 billion as of August 14, 2025. Its market cap has decreased by -26.91% in one year.
Market Cap
73.90B
Enterprise Value
66.14B
Revenue
8.33B
Ranking
n/a
PE Ratio
27.83
Stock Price
393.58
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 73.90B, an increase of 144,199.99%. That is a compound annual growth rate of 23.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 73.90B | -10.79% |
| Dec 31, 2024 | 82.84B | 0.64% |
| Dec 29, 2023 | 82.31B | 33.80% |
| Dec 30, 2022 | 61.52B | 49.20% |
| Dec 31, 2021 | 41.23B | -8.40% |
| Dec 31, 2020 | 45.01B | 5.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.13B |
| GSK plc | 56.32B |
| Haleon | 31.67B |
| Smith & Nephew | 11.73B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.93B |